Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00417-020-04703-x http://scihub22266oqcxt.onion/10.1007/s00417-020-04703-x 32328757!7179379!32328757     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Graefes+Arch+Clin+Exp+Ophthalmol 2020 ; 258 (6): 1149-1156 Nephropedia Template TP {{tp|p=32328757|t=2020. Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic |pdf=|usr=}}{{32328757}} gab.com Text Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic JO: Graefes Arch Clin Exp Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=32328757 #FOAvip PURPOSE: There is an urgent need to address how to best provide ophthalmic care for patients with retinal disease receiving intravitreal injections with anti-vascular endothelial growth factor agents during the ongoing global COVID-19 pandemic. This article provides guidance for ophthalmologists on how to deliver the best possible care for patients while minimizing the risk of infection. METHODS: The Vision Academy's Steering Committee of international retinal disease experts convened to discuss key considerations for managing patients with retinal disease during the COVID-19 pandemic. After reviewing the existing literature on the issue, members put forward recommendations that were systematically refined and voted on to develop this guidance. RESULTS: The considerations focus on the implementation of steps to minimize the exposure of patients and healthcare staff to COVID-19. These include the use of personal protective equipment, adherence to scrupulous hygiene and disinfection protocols, pre-screening to identify symptomatic patients, and reducing the number of people in waiting rooms. Other important measures include triaging of patients to identify those at the greatest risk of irreversible vision loss and prioritization of treatment visits over monitoring visits where possible. In order to limit patient exposure, ophthalmologists should refrain from using treatment regimens that require frequent monitoring. CONCLUSION: Management of patients with retinal disease receiving intravitreal injections during the COVID-19 pandemic will require adjustment to regular clinical practice to minimize the risk of exposure of patients and healthcare staff, and to prioritize those with the greatest medical need. The safety of patients and healthcare staff should be of paramount importance in all decision-making. Twit Text FOAVip Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic ????Graefes Arch Clin Exp Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=32328757 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32328757 #FOAvip English Wikipedia <ref>{{Cite pmid|32328757}}</ref> Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic #MMPMID32328757 Korobelnik JF; Loewenstein A; Eldem B; Joussen AM; Koh A; Lambrou GN; Lanzetta P; Li X; Lovestam-Adrian M; Navarro R; Okada AA; Pearce I; Rodriguez FJ; Wong DT; Wu L Graefes Arch Clin Exp Ophthalmol 2020[Jun]; 258 (6): 1149-1156 PMID32328757show ga PURPOSE: There is an urgent need to address how to best provide ophthalmic care for patients with retinal disease receiving intravitreal injections with anti-vascular endothelial growth factor agents during the ongoing global COVID-19 pandemic. This article provides guidance for ophthalmologists on how to deliver the best possible care for patients while minimizing the risk of infection. METHODS: The Vision Academy's Steering Committee of international retinal disease experts convened to discuss key considerations for managing patients with retinal disease during the COVID-19 pandemic. After reviewing the existing literature on the issue, members put forward recommendations that were systematically refined and voted on to develop this guidance. RESULTS: The considerations focus on the implementation of steps to minimize the exposure of patients and healthcare staff to COVID-19. These include the use of personal protective equipment, adherence to scrupulous hygiene and disinfection protocols, pre-screening to identify symptomatic patients, and reducing the number of people in waiting rooms. Other important measures include triaging of patients to identify those at the greatest risk of irreversible vision loss and prioritization of treatment visits over monitoring visits where possible. In order to limit patient exposure, ophthalmologists should refrain from using treatment regimens that require frequent monitoring. CONCLUSION: Management of patients with retinal disease receiving intravitreal injections during the COVID-19 pandemic will require adjustment to regular clinical practice to minimize the risk of exposure of patients and healthcare staff, and to prioritize those with the greatest medical need. The safety of patients and healthcare staff should be of paramount importance in all decision-making. |*Intravitreal Injections[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*prevention & control[MESH] |Disinfection[MESH] |Humans[MESH] |Ophthalmology/*organization & administration[MESH] |Pandemics/*prevention & control[MESH] |Personal Protective Equipment[MESH] |Pneumonia, Viral/*prevention & control[MESH] |Retinal Diseases/*drug therapy[MESH] |SARS-CoV-2[MESH]Guidance for anti-VEGF intravitreal injections during the COVID-19 pan(epmc).pdf DeepDyve Pubget Overpricing